R:\regulatory Affairs\_compliance\drug Listings\electronic\pending Approval\apremilast Tablets\version 1\apremilast Tablets V1\image-02.jpg (9abc5c32 664a 4316 A803 B73d2bf5f4d9 02)
Tacrolimus Ointment
Product Images NDC 68462-534
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 68462-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton 100g
Box packaging label for Tacrolimus 0.1% ointment, 100 g tube, for dermatologic topical use only. Label shows the product name, strength, dosage form, storage instructions, manufacturer Glenmark Pharmaceuticals Inc., USA, and usage warnings. The label states "Rx only" and instructs pharmacists to dispense with an enclosed medication guide.*
Structure.jpg (Image 01)
Chemical structure of tacrolimus, showing its detailed molecular arrangement including rings, hydroxyl groups, and methyl groups, with a water molecule (H2O) indicated as part of the structure.*
Fig1.jpg (Image 02)
A line graph depicting the percentage of body surface area affected over a 12-week period, with time in weeks on the x-axis and mean percentage body surface area affected on the y-axis. The graph compares three groups labeled Vehicle, 0.03%, and 0.1%, with data points showing changes over time and corresponding error bars indicating 95% confidence intervals.*
Fig2.jpg (Image 03)
A line graph showing the percentage of body surface area affected over a 12-week period. The graph compares two treatments: Vehicle (solid circles) and 0.03% Tacrolimus ointment (open circles). The vertical axis represents % body surface area affected with mean and 95% confidence interval, and the horizontal axis represents time in weeks.*
Fig3.jpg (Image 04)
A line graph depicting mean erythema scores (with 95% confidence intervals) over 12 weeks for three groups: Vehicle (black circles), Tacrolimus 0.03% (open circles), and Tacrolimus 0.1% (black triangles). The graph shows scores on the y-axis and time in weeks on the x-axis, with scores decreasing over time for the tacrolimus groups compared to the vehicle group.*
R:\regulatory Affairs\_compliance\drug Listings\electronic\pending Approval\apremilast Tablets\version 1\apremilast Tablets V1\image-02.jpg (Image 05)
Fig4.jpg (Image 06)
A line graph showing mean erythema score (mean ± 95% confidence interval) over 12 weeks. The x-axis represents time in weeks from 0 to 12, and the y-axis shows erythema scores from 0 to 2. Two data series compare Vehicle (black circles) and 0.03% (open circles). Erythema scores decrease over time for 0.03%, while remaining fairly constant for Vehicle.*
Tube 100g
Tacrolimus Ointment 0.1% topical ointment label displaying the product name with strength, usage instructions, storage, and cautions. Manufactured for Glenmark Pharmaceuticals Inc., USA, packaging size 100 grams. Includes directions for puncturing tube seal, a barcode, and contact information for Glenmark Pharmaceuticals.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
